Flexion Therapeutics, Inc. announced that William T. Andrews, M.D., F.A.C.P., will join the company as Chief Medical Officer (CMO), effective July 1, 2021. Dr. Andrews has more than 20 years of experience in the biopharmaceutical industry, most recently serving as CMO at Akcea Therapeutics (acquired by Ionis Pharmaceuticals). Prior to Akcea, Dr. Andrews served as CMO for Acer Therapeutics. He previously held senior leadership positions and roles of increasing responsibility at Aegerion Pharmaceuticals, Santhera Pharmaceuticals, Sepracor, and ClinQuest.